Partner Content Partner Content Registration is closing soon for SMi’s 22nd Annual Pain Ther... Registrations Closing Soon
Partner Content Partner Content Top-Level industry professionals to speak at Pain Therapeuti... 2 weeks Pain Therapeutics Conference - expert speakers
Partner Content Partner Content Due to COVID-19, Pain Therapeutics Conference, May 2020 will... COVID-19 means Pain Therapeutics Conference is Remote
Partner Content Partner Content Chair invite Kerrie Brady & Michael Scherz released ahead of... Invite from Chairs Pain Therapeutics
Partner Content Partner Content Exclusive Speaker Interview with Stephen Hunt, Professor, UC... Exclusive Speaker Interview with Stephen Hunt
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.